Increased complications of COVID-19 in people with cardiovascular disease: Role of the renin–angiotensin-aldosterone system (RAAS) dysregulation
<p dir="ltr">The rapid spread of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) that causes coronavirus disease 2019 (COVID‐19), has had a dramatic negative impact on public health and economies worldwide. Recent studies on COVID-19 complications and mortality rates sug...
محفوظ في:
| المؤلف الرئيسي: | |
|---|---|
| مؤلفون آخرون: | , , , , , , , , , , |
| منشور في: |
2022
|
| الموضوعات: | |
| الوسوم: |
إضافة وسم
لا توجد وسوم, كن أول من يضع وسما على هذه التسجيلة!
|
| _version_ | 1864513552565403648 |
|---|---|
| author | Robin Augustine (3976964) |
| author2 | Abhilash S (17151130) Ajisha Nayeem (17151133) Shaheen Abdul Salam (17151136) Priya Augustine (17151139) Pan Dan (5938505) Pablo Maureira (3599633) Fatima Mraiche (715733) Carmine Gentile (4668727) Philip M. Hansbro (7501037) Lana McClements (282400) Anwarul Hasan (1332066) |
| author2_role | author author author author author author author author author author author |
| author_facet | Robin Augustine (3976964) Abhilash S (17151130) Ajisha Nayeem (17151133) Shaheen Abdul Salam (17151136) Priya Augustine (17151139) Pan Dan (5938505) Pablo Maureira (3599633) Fatima Mraiche (715733) Carmine Gentile (4668727) Philip M. Hansbro (7501037) Lana McClements (282400) Anwarul Hasan (1332066) |
| author_role | author |
| dc.creator.none.fl_str_mv | Robin Augustine (3976964) Abhilash S (17151130) Ajisha Nayeem (17151133) Shaheen Abdul Salam (17151136) Priya Augustine (17151139) Pan Dan (5938505) Pablo Maureira (3599633) Fatima Mraiche (715733) Carmine Gentile (4668727) Philip M. Hansbro (7501037) Lana McClements (282400) Anwarul Hasan (1332066) |
| dc.date.none.fl_str_mv | 2022-01-05T00:00:00Z |
| dc.identifier.none.fl_str_mv | 10.1016/j.cbi.2021.109738 |
| dc.relation.none.fl_str_mv | https://figshare.com/articles/journal_contribution/Increased_complications_of_COVID-19_in_people_with_cardiovascular_disease_Role_of_the_renin_angiotensin-aldosterone_system_RAAS_dysregulation/24314341 |
| dc.rights.none.fl_str_mv | CC BY 4.0 info:eu-repo/semantics/openAccess |
| dc.subject.none.fl_str_mv | Biomedical and clinical sciences Cardiovascular medicine and haematology Pharmacology and pharmaceutical sciences Cardiovascular diseases COVID-19 Coronavirus SARS-CoV-2 RAAS ACE2 |
| dc.title.none.fl_str_mv | Increased complications of COVID-19 in people with cardiovascular disease: Role of the renin–angiotensin-aldosterone system (RAAS) dysregulation |
| dc.type.none.fl_str_mv | Text Journal contribution info:eu-repo/semantics/publishedVersion text contribution to journal |
| description | <p dir="ltr">The rapid spread of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) that causes coronavirus disease 2019 (COVID‐19), has had a dramatic negative impact on public health and economies worldwide. Recent studies on COVID-19 complications and mortality rates suggest that there is a higher prevalence in cardiovascular diseases (CVD) patients. Past investigations on the associations between pre-existing CVDs and susceptibility to coronavirus infections including SARS‐CoV and the Middle East Respiratory Syndrome coronavirus (MERS-CoV), have demonstrated similar results. However, the underlying mechanisms are poorly understood. This has impeded adequate risk stratification and treatment strategies for CVD patients with SARS-CoV-2 infections. Generally, dysregulation of the expression of angiotensin‐converting enzyme (ACE) and the counter regulator, angiotensin‐converting enzyme 2 (ACE2) is a hallmark of cardiovascular risk and CVD. ACE2 is the main host receptor for SARS-CoV-2. Although further studies are required, dysfunction of ACE2 after virus binding and dysregulation of the renin-angiotensin-aldosterone system (RAAS) signaling may worsen the outcomes of people affected by COVID-19 and with preexisting CVD. Here, we review the current knowledge and outline the gaps related to the relationship between CVD and COVID-19 with a focus on the RAAS. Improved understanding of the mechanisms regulating viral entry and the role of RAAS may direct future research with the potential to improve the prevention and management of COVID-19.</p><h2>Other Information</h2><p dir="ltr">Published in: Chemico-Biological Interactions<br>License: <a href="http://creativecommons.org/licenses/by/4.0/" target="_blank">http://creativecommons.org/licenses/by/4.0/</a><br>See article on publisher's website: <a href="https://dx.doi.org/10.1016/j.cbi.2021.109738" target="_blank">https://dx.doi.org/10.1016/j.cbi.2021.109738</a></p> |
| eu_rights_str_mv | openAccess |
| id | Manara2_8c8a58686ddfd6a8bdcc1aa2a3fc7da9 |
| identifier_str_mv | 10.1016/j.cbi.2021.109738 |
| network_acronym_str | Manara2 |
| network_name_str | Manara2 |
| oai_identifier_str | oai:figshare.com:article/24314341 |
| publishDate | 2022 |
| repository.mail.fl_str_mv | |
| repository.name.fl_str_mv | |
| repository_id_str | |
| rights_invalid_str_mv | CC BY 4.0 |
| spelling | Increased complications of COVID-19 in people with cardiovascular disease: Role of the renin–angiotensin-aldosterone system (RAAS) dysregulationRobin Augustine (3976964)Abhilash S (17151130)Ajisha Nayeem (17151133)Shaheen Abdul Salam (17151136)Priya Augustine (17151139)Pan Dan (5938505)Pablo Maureira (3599633)Fatima Mraiche (715733)Carmine Gentile (4668727)Philip M. Hansbro (7501037)Lana McClements (282400)Anwarul Hasan (1332066)Biomedical and clinical sciencesCardiovascular medicine and haematologyPharmacology and pharmaceutical sciencesCardiovascular diseasesCOVID-19CoronavirusSARS-CoV-2RAASACE2<p dir="ltr">The rapid spread of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) that causes coronavirus disease 2019 (COVID‐19), has had a dramatic negative impact on public health and economies worldwide. Recent studies on COVID-19 complications and mortality rates suggest that there is a higher prevalence in cardiovascular diseases (CVD) patients. Past investigations on the associations between pre-existing CVDs and susceptibility to coronavirus infections including SARS‐CoV and the Middle East Respiratory Syndrome coronavirus (MERS-CoV), have demonstrated similar results. However, the underlying mechanisms are poorly understood. This has impeded adequate risk stratification and treatment strategies for CVD patients with SARS-CoV-2 infections. Generally, dysregulation of the expression of angiotensin‐converting enzyme (ACE) and the counter regulator, angiotensin‐converting enzyme 2 (ACE2) is a hallmark of cardiovascular risk and CVD. ACE2 is the main host receptor for SARS-CoV-2. Although further studies are required, dysfunction of ACE2 after virus binding and dysregulation of the renin-angiotensin-aldosterone system (RAAS) signaling may worsen the outcomes of people affected by COVID-19 and with preexisting CVD. Here, we review the current knowledge and outline the gaps related to the relationship between CVD and COVID-19 with a focus on the RAAS. Improved understanding of the mechanisms regulating viral entry and the role of RAAS may direct future research with the potential to improve the prevention and management of COVID-19.</p><h2>Other Information</h2><p dir="ltr">Published in: Chemico-Biological Interactions<br>License: <a href="http://creativecommons.org/licenses/by/4.0/" target="_blank">http://creativecommons.org/licenses/by/4.0/</a><br>See article on publisher's website: <a href="https://dx.doi.org/10.1016/j.cbi.2021.109738" target="_blank">https://dx.doi.org/10.1016/j.cbi.2021.109738</a></p>2022-01-05T00:00:00ZTextJournal contributioninfo:eu-repo/semantics/publishedVersiontextcontribution to journal10.1016/j.cbi.2021.109738https://figshare.com/articles/journal_contribution/Increased_complications_of_COVID-19_in_people_with_cardiovascular_disease_Role_of_the_renin_angiotensin-aldosterone_system_RAAS_dysregulation/24314341CC BY 4.0info:eu-repo/semantics/openAccessoai:figshare.com:article/243143412022-01-05T00:00:00Z |
| spellingShingle | Increased complications of COVID-19 in people with cardiovascular disease: Role of the renin–angiotensin-aldosterone system (RAAS) dysregulation Robin Augustine (3976964) Biomedical and clinical sciences Cardiovascular medicine and haematology Pharmacology and pharmaceutical sciences Cardiovascular diseases COVID-19 Coronavirus SARS-CoV-2 RAAS ACE2 |
| status_str | publishedVersion |
| title | Increased complications of COVID-19 in people with cardiovascular disease: Role of the renin–angiotensin-aldosterone system (RAAS) dysregulation |
| title_full | Increased complications of COVID-19 in people with cardiovascular disease: Role of the renin–angiotensin-aldosterone system (RAAS) dysregulation |
| title_fullStr | Increased complications of COVID-19 in people with cardiovascular disease: Role of the renin–angiotensin-aldosterone system (RAAS) dysregulation |
| title_full_unstemmed | Increased complications of COVID-19 in people with cardiovascular disease: Role of the renin–angiotensin-aldosterone system (RAAS) dysregulation |
| title_short | Increased complications of COVID-19 in people with cardiovascular disease: Role of the renin–angiotensin-aldosterone system (RAAS) dysregulation |
| title_sort | Increased complications of COVID-19 in people with cardiovascular disease: Role of the renin–angiotensin-aldosterone system (RAAS) dysregulation |
| topic | Biomedical and clinical sciences Cardiovascular medicine and haematology Pharmacology and pharmaceutical sciences Cardiovascular diseases COVID-19 Coronavirus SARS-CoV-2 RAAS ACE2 |